Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Non Operating Income (2023 - 2025)

Camp4 Therapeutics' Non Operating Income history spans 3 years, with the latest figure at -$27.5 million for Q4 2025.

  • For Q4 2025, Non Operating Income fell 3743.44% year-over-year to -$27.5 million; the TTM value through Dec 2025 reached -$27.8 million, down 3550.81%, while the annual FY2025 figure was -$27.8 million, 2247.11% down from the prior year.
  • Non Operating Income for Q4 2025 was -$27.5 million at Camp4 Therapeutics, down from -$1.4 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $755000.0 in Q4 2024 and bottomed at -$27.5 million in Q4 2025.
  • The 3-year median for Non Operating Income is $86000.0 (2024), against an average of -$3.0 million.
  • The largest YoY upside for Non Operating Income was 2282.14% in 2025 against a maximum downside of 3743.44% in 2025.
  • A 3-year view of Non Operating Income shows it stood at $486000.0 in 2023, then skyrocketed by 55.35% to $755000.0 in 2024, then tumbled by 3743.44% to -$27.5 million in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Non Operating Income are -$27.5 million (Q4 2025), -$1.4 million (Q3 2025), and $441000.0 (Q2 2025).